New hope for lymphoma: immune booster plus chemotherapy trial launches
Disease control
Not yet recruiting
This Phase 2 trial tests whether adding epcoritamab, an immune-boosting drug, to standard R-CHOP chemotherapy can safely treat newly diagnosed aggressive B-cell lymphoma. About 20 adults with certain lymphoma types will receive the combination. The main goal is to check for a sid…
Phase 2 • Sponsor: Carrie Ho, MD • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC